Skip to main content

Candriam S.C.A.

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1537014 STRASSEN, N4

Position in ALNY

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$94,677,547
+$20,453,480 QoQ
Shares Held
314,512
+40.2% QoQ
Ownership
0.235%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#54
of 784 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALNY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Candriam S.C.A. holds $2,107,868,027 across 75 Biotechnology names. ALNY ranks #4 (4.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 ALNY
Alnylam Pharmaceuticals, Inc.
This page
314,512 $94,677,547

All Filings in ALNY

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $94,677,547 314,512
2026-03-31 $74,224,067 224,330
2025-12-31 $89,204,824 224,330
2025-09-30 $96,861,696 212,416
2025-06-30 $77,636,811 238,084
2025-03-31 $67,483,128 249,919
2024-12-31 $66,453,191 282,407
2024-09-30 $96,719,250 351,668
2024-06-30 $85,348,404 351,228
2024-03-31 $47,360,406 316,898
2023-12-31 $47,926,001 250,384
2023-09-30 $58,247,127 328,894
2023-06-30 $60,570,726 318,894
2023-03-31 $65,763,253 328,291
2022-12-31 $76,165,636 320,495
2022-09-30 $70,666,087 353,048
2022-06-30 $50,057,616 343,213
2022-03-31 $49,583,498 303,653
2021-12-31 $40,796,030 240,571
2021-09-30 $25,126,645 133,079
2021-06-30 $29,635,825 174,822
2021-03-31 $22,951,564 162,558
2020-12-31 $21,127,663 162,558
2020-09-30 $24,402,560 167,600
2020-06-30 $24,823,236 167,600
2020-03-31 $20,761,178 190,732